Ridgetech (RDGT)

The company’s core activity is retail pharmacy. Through its drugstore operations, Ridgetech sells prescription medicines, over-the-counter treatments, traditional Chinese medicine products, nutritional and dietary supplements, medical devices, and everyday health-related items. This retail channel is the company’s most important source of revenue and positions it in a market shaped by ageing demographics, rising healthcare consumption, and demand for convenient access to medicines.

Ridgetech also operates an online pharmacy business, using large third-party e-commerce platforms to reach customers beyond its physical store footprint. Its products are offered through marketplaces such as Alibaba’s Tmall, JD.com, and Amazon.com, giving the company exposure to China’s well-developed digital commerce infrastructure and to changing consumer habits around pharmacy purchasing.

A third part of the business is drug wholesale, through which Ridgetech distributes pharmaceutical products to institutional or commercial customers. Together, the retail, online, and wholesale segments give the company multiple routes to market across China’s fragmented healthcare distribution chain. For investors, RDGT represents a small-cap equity tied to pharmacy retailing, digital healthcare commerce, and the broader demand for accessible medicines and wellness products.